Complications with totally implantable venous access device: A retrospective study of 116 cases;Complications des chambres à cathéter implantables: Étude rétrospective de 116 cas

Presse Medicale

Volumn 32, Issue 27, 2003, Pages 1263-1268

  Talfer, Serge ^a   Conessa, Claude ^a   Hervé, Stéphane ^a   Roguet, Éric ^a   De Rotalier, Pierre ^a   Poncet, Jean Luc ^a  

^a University of Paris Descartes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANESTHESIA INDUCTION; ARTICLE; CATHETER INFECTION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEVICE; FEMALE; FOLLOW UP; FRANCE; GENERAL ANESTHESIA; HEMATOMA; HUMAN; IMPLANTATION; INTERNAL JUGULAR VEIN; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SEPTICEMIA; SUBCLAVIAN VEIN; TOTALLY IMPLANTABLE VENOUS ACCESS DEVICE;

ADULT; AGED; AGED, 80 AND OVER; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; EQUIPMENT FAILURE; FEMALE; HEMATOMA; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SEPSIS; VENOUS THROMBOSIS;

EID: 0042320389     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Borst CG, de Kruif AT, van Dam FS, de Graaf PW. Totally implantable venous access ports, the patients' point of view. A quality control study. Cancer Nurs 1992; 15: 378-81.
2. Carde P, Cosset-Delaigue MF, Laplanche A, Chareau I. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol 1989; 25: 939-44.
3. Defraigne JO, Closon MT, Bruyninx L et al. Experience with a totally implantable catheter in adult patients: a single institution retrospective study of 114 cases. Eur J Surg Oncol 1989; 15: 61-4.
4. Trabacchi G. Dispositifs intraveineux de longue durée et soins à domicile. Soins 2001 Nov; (660): 33.
5. Boussen H, Mtaallah M, Dhiab T et al. Évaluation des sites implantables en cancérologie médicale en tunisie. Etude prospective à propos de 205 cas. Ann Fr Anesth Reanim 2001; 20: 509-13.
6. Mallaret M. R, Olive F, Fauconnier J et al. Surveillance épidémiologique des infections de cathéters à chambre implantable. Méd Mal Infect 1996; 26: 752-6.
7. Groegger JS, Lucas AB, Thaler HT et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993; 119: 1168-74.
8. Coton T, Bonnet D, Pinot JJ et al. Complication inhabituelle de l'utilisation des chambres implantables en oncologie. Rev Pneumol Clin 1995; 51: 351-3.
9. Paoli C, Bassot V, el-Bez M. et al. Cancérologie cervico-faciale: complications des systèmes d'accès veineux implantable, étude rétrospective. Presse Med 1994; 23: 649-52.
10. Poorter RL, Lauw FN, Bemelman WA, Bakker PJ, Taat CW, Veenhof CH. Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy. Eur J Cancer 1996; 32: 2262-6.
11. Funaki B, Szymski GX, Hackworth CA et al. Radiologic placement of subcutaneous infusion chest ports for long-term central venous access. AJR 1997; 169: 1431-4.
12. Morris SL, Jaques PF, Mauro MA. Radiology-assisted placement of implantable subcutaneous infusion ports for long-term venous access. Radiologie 1992; 184: 149-51.
13. Di Carlo I, Cordio S, La Greca G et al. Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg 2001; 136: 1050-3.
14. Petersen J, Delaney JH, Brakstad MT, Rowbotham RK, Bagley CM Jr. Silicone venous access devices positioned with their tips high in the superior vena cava are more likely to malfunction. Am J Surg 1999;178:38-41.
15. Barbut F, Guiguet M, Reynaud F et al. Cathéters veineux centraux. Surveillance prospective sur l'ensemble d'un hôpital. Presse Med 1997; 26: 656-62.
16. Rackoff WR, Weiman M, Jakobowski D et al. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr 1995; 127: 147-51.
17. Brion J P, Barnoud D, Mallaret M. R. Place du verrou antibiotique dans le traitement des infections de chambre à cathéter implantable. Med Mal Infect 1998; 28: 461-8
18. Hubsch PJ, Stiglbauer RL, Schwaighofer BW, Kainberger FM, Barton PR. Internal jugular and subclavian vein thrombosis caused by central venous catheters. Evaluation using Doppler blood flow imaging. J Ultrasound Med 1988; 7: 629-36.
19. Pucheu A, Leduc B, Sillet-Bach I, Payen C, Assaf W, Pucheu M. Experimental prevention of deep venous thrombosis with low-molecular-weight heparin using implantable infusion devices. Ann Cardiol Angeiol 1996; 45: 59-63.
20. Bonfils P, Luciani JA, Potard G, Bassot V. Etude rétrospective des thromboses de la reine sous-clavière après mise en place d'un système d'accès veineux implantable en cancérologie cervico-faciale. Ann Otolaryngol Chir Cervicofac 1996; 113: 425-9.
21. Pucheu A, Dierhas M, Leduc B et al. Fibrinolyse des thromboses veineuses profondes sur dispositifs de perfusion implantable. Å propos d'une série consécutive de 57 thromboses et de 32 fibrinolyses. Bull Cancer 1996; 83: 293-9.
22. Wen YR, Ho WY, Sun WZ, Or CH, Yeh M, Yao WC, Tai YT. Thromboelastographic study of thrombosis in the implantable central venous access device. Acta Anaesthesiol Sin 1997; 35: 223-8.
23. Yung B, Elborn JS, Campbell IA, Summers Y, Beckles M, Woodcock AA. Thromboembolism related to a Port-a-Cath device in a patient with cystic fibrosis. Thorax 1997; 52: 98-9.
24. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998; 133: 770-6.
25. Gratadou D, Elias A, Elias M, Boccalon H. Thromboses veineuses sur cathéters centraux en cancérologie, Presse Med 2001; 30: 298-301.
26. Bern M, Lokich J, Wallach S et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomised prospective trial. Ann Intern Med 1990; 112: 423-8.
27. Minassian VA, Sood AK, Lowe P, Sorosky JI, Al-Jurf AS, Buller RE. Longterm central venous access in gynecologic cancer patients. J Am Coll Surg 2000; 191: 403-9.
28. Champault G. Cathéters totalement implantables pour chimiothérapie anticancéreuse. Expérience française de 325 cas. J Chir (Paris) 1985; 122: 269-72.
29. Bazelly B, Lotz JP, Milleron B. Réflexions sur l'entretien des sites de perfusion totalement implantables. Rev Pneumo Clin 1994; 50:43-4.
30. CCLIN. Recommandations pour la réduction du risque infectieux lié aux chambres à cathéter implantables. Groupe de travail CCLIN Sud-ouest 2001.